DepressionPhase 1NCT00386711
A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care
A Phase 1 study testing training on identification of suicide risk and depression in people with Depression and Suicide, run by Nanjing Medical University at 1 site in China.
Trial summary
improve detection and management of suicide risk among depressed patients in primary care Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Depression, Suicide
- What is being tested?
- training on identification of suicide risk and depression
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 2,160 participants
- Where
- 1 siteChina
- Study dates
- Oct 2006to Jan 2007
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- consecutive outpatient
Who cannot join
- severe physical conditions
Trial locations and contacts
1 site in 1 country.
China1 site
Nanjing Brain Hospital
Nanjing, Jiangsu, 210029
Yong Tang, doctor, 13851603705, tangyong1967@gmail.com
About this study
improve detection and management of suicide risk among depressed patients in primary care
Read the detailed description
After intervention of training on the identification and management of depression and suicide risk in primary health care professionals, the ability of detection and management of suicide risk among depressed patients in primary care is expected to be improved compared to baseline evaluation.
- Conditions
- Depression, Suicide
- Being tested
- training on identification of suicide risk and depression
- Keywords
- suicide, depressed patients, primary care
- Medical subject headings
- Depression, Suicide
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
training on identification of suicide risk and depressionBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
Kappa of diagnostic consistency
Secondary outcomes (1)
ratio of optimal managment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Oct 2006 (estimated)
- Study startOct 2006
- Study completionJan 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DepressionStudies of the same condition, open and under way.
- More trials run by Nanjing Medical UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Enrolment
- 2,160 participants
Sponsor and investigators
- Lead sponsor
- Nanjing Medical University
- Sponsor type
- University, hospital or other
- Investigators
- SHUTAO ZHAI, DOCTOR, Study director, Nanjing Brain Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00386711
- Sponsor's protocol ID
- NBH038
- Status last verified
- Oct 2006
- First submitted
- 10 Oct 2006
- Last updated
- 12 Oct 2006
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Oct 2006. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care
- ClinicalTrials.gov ID
- NCT00386711
- Acronym / sponsor ID
- NBH038
- Conditions
- Depression, Suicide
- Keywords
- suicide, depressed patients, primary care
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 2,160 participants
- Lead sponsor
- Nanjing Medical UniversityUniversity, hospital or other
- Study start
- Oct 2006
- Study completion
- Jan 2007
- First posted
- 12 Oct 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
improve detection and management of suicide risk among depressed patients in primary care
Detailed description
After intervention of training on the identification and management of depression and suicide risk in primary health care professionals, the ability of detection and management of suicide risk among depressed patients in primary care is expected to be improved compared to baseline evaluation.
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- consecutive outpatient
Key exclusion criteria (1 listed)
- severe physical conditions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| training on identification of suicide risk and depression | Behavioural | – |
Primary outcome
Kappa of diagnostic consistency
1 secondary outcome
ratio of optimal managment
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Oct 2006.
Related trials for Depression
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Recruiting
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
SHUTAO ZHAI, DOCTOR study director
Nanjing Brain Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing training on identification of suicide risk and depression in people with Depression and Suicide, run by Nanjing Medical University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 12 Oct 2006. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Yong Tang, Doctor (13851603705, tangyong1967@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Kappa of diagnostic consistency. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2006.